CSL LIMITED SHAREHOLDER REVIEW[removed] CSL Limited ABN[removed]Shareholder Review[removed]

First Page		Document Content
Date: 2009-10-22 08:48:25 Vaccines Canada Steamship Lines Dividend Papillomavirus Special dividend Computershare Behring Gardasil CSL Limited CSL Behring Dividends		CSL LIMITED SHAREHOLDER REVIEW[removed] CSL Limited ABN[removed]Shareholder Review[removed] Add to Reading List Source URL: www.csl.com.au Download Document from Source Website File Size: 239,51 KB Share Document on Facebook

	CSL Behring AG WankdorfstrasseBern 22 Switzerland sitem-insel AG DocID: 1uREs - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1sx8q - View Document
	Uwe E. Jocham Direktionspräsident CSL Behring Recombinant Facility AG, Lengnau/Schweiz Uwe E. Jocham, geboren in Frankfurt, Deutschland, studierte Pharmazie an der LudwigMaximilians-Universität (LMU) in München. Nach DocID: 1sesH - View Document
	MAJOR THERAPEUTIC PRODUCTS MARKETED by CSL Behring Hematology Specialty Care DocID: 1sb17 - View Document
	[Product Monograph Template - Schedule D] DocID: 1rjWd - View Document